Related Experiment Video
Updated: Jun 7, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes
N Cordani1, S Pozzi, E Martynova
1Dipartimento di Scienze Biomolecolari e Biotecnologie, Università degli Studi di Milano Via Celoria 26, Milano, Italy.
Abstract:
Genetic experiments established that p63 is crucial for the development and maintenance of pluri-stratified epithelia and KLF4 for the barrier function of the skin. KLF4 is one of the factors that reprogram differentiated cells to iPS. We investigated the relationship between p63 and KLF4 using RNA interference, overexpression, chromatin immunoprecipitation and transient transfections with reporter constructs. We find that p63 directly represses KLF4 in normal keratinocytes (KCs) by binding to upstream promoter sites. Unlike p63, KLF4 levels are high in the upper layers of human skin and increase upon differentiation of KCs in vitro. In HaCaT KCs, which harbor two mutant alleles of p53, inactivation of p63 and of mutant p53 leads to KLF4 repression. p63 and p53 mutants are bound to sites in the KLF4 core promoter. Importantly, expression of the H179Y and R282Q p53 mutants in primary KCs is sufficient to activate endogenous KLF4. Finally, immunohistochemical analysis of tissue arrays confirms increased coexpression of KLF4 and mutant p53 in squamous cell carcinomas. Our data indicate that suppression of KLF4 is part of the growth-promoting strategy of p63 in the lower layers of normal epidermis, and that tumor-predisposing p53 mutations hijack p63 to a different location on the promoter, turning it into an activator of this reprogramming factor.
Insights
p63 protein suppresses KLF4 in normal skin cells, but mutations in p53 can cause p63 to activate KLF4, promoting squamous cell carcinoma growth.
Area of Science:
- Molecular Biology
- Cell Biology
- Dermatology
Background:
- p63 is essential for stratified epithelial development and maintenance.
- KLF4 is critical for skin barrier function and cellular reprogramming.
- The interplay between p63 and KLF4 in keratinocytes is not fully understood.
Purpose of the Study:
- To elucidate the regulatory relationship between p63 and KLF4 in keratinocytes.
- To investigate the role of p53 mutations in modulating p63-KLF4 interactions.
Main Methods:
- RNA interference and overexpression studies.
- Chromatin immunoprecipitation assays.
- Reporter construct transfections and immunohistochemical analysis.
Main Results:
- p63 directly represses KLF4 in normal keratinocytes by binding to promoter regions.
- KLF4 expression is higher in upper skin layers and increases with keratinocyte differentiation.
- Mutant p53, in conjunction with p63 inactivation, represses KLF4, while p53 mutants can activate KLF4.
- Increased coexpression of KLF4 and mutant p53 is observed in squamous cell carcinomas.
Conclusions:
- p63's suppression of KLF4 is a growth-promoting mechanism in normal epidermis.
- Tumor-predisposing p53 mutations alter p63 binding to the KLF4 promoter, converting it into an activator.
- This mechanism highlights how p53 mutations can drive cancer by manipulating key developmental factors like KLF4.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

